- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01223430
Simultaneously Using Traditional Chinese Medicine (Si-Ni-Tang) to Treat Septic Shock Patients
May 21, 2012 updated by: Huang-Chi Chen, Changhua Christian Hospital
Simultaneously Using Traditional Chinese Medicine (Si-Ni-Tang) to Treat Septic Shock Patients - a Double Blind, Prospective, Randomized Controlled Study
The purpose of this study is to determine whether simultaneously using the traditional Chinese medicine, Si-Ni-Tang, is more effective in the treatment of septic shock patients.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Those with hemodynamic instability were the main population of the ICU patients, whether the exact etiology leading to the diseases.
However, how to maintain adequate hemodynamic status in order to keep the patients with well organs perfusion is the main issue of the intensive care physicians.
The choices of vasoactive drugs in the guidelines or experts' suggestions nowadays used are still limited in the western medicine.
Si-Ni-Tang, a remedy previously used in ancient China and now widely prescribed in Taiwan and China, is used for treating patients diagnosed as shock or heart failure.
The investigators are eager to know if there existed any benefit via adding this drug to treat the septic shock patients.
Therefore, the investigators designed a prospectively randomized double blind control trial to determine whether simultaneously using the traditional Chinese medicine, Si-Ni-Tang, is more effective in the treatment of septic shock patients.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Changhua, Taiwan, 500
- Medical ICU, Changhua Christian Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients admitted to our intensive care units are enrolled if their disease diagnosis meets the definition of septic shock
- Using vasopressor now and the duration from initiation of vasopressor use to the entrance of the study is within 24 hours
- Nasogastric tube feeding
Exclusion Criteria:
- More than one kind of vasopressor is administrated
- Patients with extremely poor gastrointestinal function and can not tolerate diet feeding
- Acute myocardial infarction
- Patients with evidence of major bleeding
- Expected surgical intervention or scheduled surgery in the subsequent one week
- Patients who received digoxin for arrhythmia in the past one week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
The prescription is 2.25 grams four times a day ( 9 grams per day) for 7 days or till shock reversal( if shock reversal < 1 week).
Shock reversal was defined as the discontinuation of norepinephrine or dopamine lasting for at least 24 hours.
|
Experimental: Si-Ni-Tang
|
The prescription is 2.25 grams four times a day ( 9 grams per day) for 7 days or till shock reversal( if shock reversal < 1 week).
Shock reversal was defined as the discontinuation of norepinephrine or dopamine lasting for at least 24 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
time to cessation of vasopressor use
Time Frame: one week
|
one week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
intensive care unit (ICU) mortality
Time Frame: one month
|
one month
|
ICU length of stay
Time Frame: one month
|
one month
|
28-day survival rate
Time Frame: one month
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Huang-Chi CHEN, M.D., Changhua Christian Hospital, TAIWAN
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
October 18, 2010
First Submitted That Met QC Criteria
October 18, 2010
First Posted (Estimate)
October 19, 2010
Study Record Updates
Last Update Posted (Estimate)
May 23, 2012
Last Update Submitted That Met QC Criteria
May 21, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCH IRB 100105
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated...Recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
National Taiwan University HospitalBaxter Healthcare CorporationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityUnknown
Clinical Trials on Si-Ni-Tang/ Placebo of Si-Ni-Tang
-
Guangdong Provincial Hospital of Traditional Chinese...Completed
-
Chung Shan Medical UniversityCompletedGynecological Disorders
-
DR. MALA KHANDhaka Medical CollegeCompleted
-
Light Chain Bioscience - Novimmune SACompletedModerate to Severe Crohn's Disease
-
Gachon University Gil Oriental Medical HospitalKyung Hee University Hospital at Gangdong; Kyunghee University Medical Center; Sangji University Oriental Medical Hospital and other collaboratorsCompletedCold HypersensitivityKorea, Republic of
-
Guangzhou University of Traditional Chinese MedicineUniversity of HoustonRecruitingXiao Chai Hu Tang | Irinotecan-induced DiarrheaChina
-
Peking University Third HospitalNot yet recruitingInfertility, Female
-
Novo Nordisk A/SCompleted
-
Peking University Third HospitalRecruiting
-
Jazz PharmaceuticalsCompletedEpilepsySpain, United Kingdom